Abstract | PURPOSE: SUMMARY: CONCLUSION:
|
Authors | Anne Ottney |
Journal | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
(Am J Health Syst Pharm)
Vol. 70
Issue 23
Pg. 2097-103
(Dec 01 2013)
ISSN: 1535-2900 [Electronic] England |
PMID | 24249759
(Publication Type: Comparative Study, Journal Article, Review)
|
Chemical References |
- GLP1R protein, human
- Glucagon-Like Peptide-1 Receptor
- Lactones
- Peptides
- Receptors, Glucagon
- Venoms
- Liraglutide
- Glucagon-Like Peptide 1
- Orlistat
- Exenatide
|
Topics |
- Adult
- Dose-Response Relationship, Drug
- Exenatide
- Glucagon-Like Peptide 1
(adverse effects, analogs & derivatives, pharmacology, therapeutic use)
- Glucagon-Like Peptide-1 Receptor
- Humans
- Lactones
(adverse effects, pharmacology, therapeutic use)
- Life Style
- Liraglutide
- Obesity
(drug therapy, physiopathology)
- Orlistat
- Peptides
(adverse effects, pharmacology, therapeutic use)
- Receptors, Glucagon
(agonists)
- Treatment Outcome
- Venoms
(adverse effects, pharmacology, therapeutic use)
- Weight Loss
(drug effects)
|